<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Vaccination</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Vaccination.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/topics/vaccination.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Whole-genome analysis of mumps virus genotype F in Shandong, China (2006–2018)</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-fmicb-2026-1912439-d3184f7c/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-fmicb-2026-1912439-d3184f7c/</guid>
    <pubDate>Wed, 09 Sep 2026 00:00:00 GMT</pubDate>
    <description>Mumps incidence in Shandong declined after vaccine introduction but remained above WHO elimination thresholds; the study provides whole-genome evidence that genotype F strains did not detectably diverge or drift away from the vaccine strain over ~12 years, while illustrating that SH-gene typing alone lacks resolution for closely related isolates.</description>
    <category>Mumps</category>
    <category>Rubella</category>
    <category>Measles</category>
    <category>Surveillance</category>
    <category>Vaccination</category>
    <category>Genomic epidemiology</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>Parent-driven transmission, off-label SMZ-TMP, and severe pertussis prediction in infants under 2 months: a real-world observational cohort of 527 cases</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-fped-2026-1815371-0ff051d4/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-fped-2026-1815371-0ff051d4/</guid>
    <pubDate>Wed, 09 Sep 2026 00:00:00 GMT</pubDate>
    <description>The findings provide context on reported household-source patterns, clinical features associated with severe disease, and treatment practices in hospitalized young infants with pertussis. The abstract may inform editorial discussion of vulnerable infant populations and antimicrobial management, but it does not establish population-wide prevalence or representativeness.</description>
    <category>Pertussis</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Post-marketing safety surveillance of tetanus, diphtheria, and acellular pertussis (Tdap) vaccine: a disproportionality analysis of the vaccine adverse event reporting system (2015–2025)</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-fcimb-2026-1831548-a72456c2/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-fcimb-2026-1831548-a72456c2/</guid>
    <pubDate>Tue, 08 Sep 2026 00:00:00 GMT</pubDate>
    <description>The paper addresses post-marketing vaccine safety surveillance for a routinely recommended vaccine. Its relevance is strongest for safety signal detection and hypothesis generation in Tdap vaccination programs.</description>
    <category>Pertussis</category>
    <category>Diphtheria</category>
    <category>Tetanus</category>
    <category>Vaccination</category>
    <category>Surveillance</category>
    <category>Vaccine safety</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Implementing an intra outbreak ring vaccination clinical trial for Sudan Ebola virus disease within four days of outbreak notification in Uganda.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1080-22221751-2026-2731496-7d1abb29/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1080-22221751-2026-2731496-7d1abb29/</guid>
    <pubDate>Mon, 07 Sep 2026 00:00:00 GMT</pubDate>
    <description>The four-day turnaround provides a replicable blueprint for rapid medical countermeasure evaluation during future outbreaks in settings with heightened Ebola Virus Disease threat. The approach demonstrates that prepositioned protocols, established infrastructure, and trained personnel can dramatically compress trial activation timelines.</description>
    <category>Ebola</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Convalescent Plasma Restores Viral Clearance After Anti-Spike Monoclonal Antibody Failure in Immunocompromised COVID-19 Patients: A Systematic Review and Meta-Analysis of Individual Patient Data.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1002-rmv-70185-e1988ad7/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1002-rmv-70185-e1988ad7/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>The findings concern a treatment option for immunocompromised patients with persistent infection after monoclonal antibody failure, but the supplied abstract does not establish comparative effectiveness or causality.</description>
    <category>SARS</category>
    <category>COVID-19</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Timing, Titre, and Host Determinants of Convalescent Plasma Efficacy in COVID-19: A Systematic Review With Design-Stratified Narrative Synthesis.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1002-rmv-70189-831219ed/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1002-rmv-70189-831219ed/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>Clarifying these operational parameters supports more precise therapeutic allocation and establishes a methodological framework for managing future infectious disease crises.</description>
    <category>SARS</category>
    <category>COVID-19</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Transmission dynamics</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Clinical impact of childhood and adolescence dengue vaccination in Indonesia: A dynamic transmission modeling study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-epidem-2026-100932-1bed4d95/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-epidem-2026-100932-1bed4d95/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>The results suggest that prioritizing early childhood immunization could meaningfully decrease national dengue incidence if a broadly protective vaccine becomes available.</description>
    <category>Dengue</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Mathematical modelling</category>
  </item>
  <item>
    <title>Interferon-gamma release assays versus tuberculin skin test for latent tuberculosis infection positivity among healthcare workers and first responders: a systematic review and meta-analysis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-108949-15282287/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-108949-15282287/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>Latent tuberculosis infection remains common among healthcare workers, and positivity estimates vary substantially by diagnostic method. The association of TST positivity with BCG vaccination suggests IGRA may offer greater specificity for screening BCG-vaccinated occupational groups.</description>
    <category>Tuberculosis</category>
    <category>Vaccination</category>
    <category>Diagnostics</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Mixing versus matching booster vaccines: A longitudinal humoral immune kinetics against Omicron in a Malaysian cohort</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-109103-7003aecc/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-109103-7003aecc/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>The findings offer immunogenicity evidence relevant to booster vaccination strategy decisions during Omicron-era outbreaks, with particular relevance to settings where inactivated virus priming is used.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>The 2026 Bundibugyo virus disease outbreak in the Democratic Republic of the Congo: Virology, epidemiology, continental response, and research priorities</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-imj-2026-100270-6c5ddd42/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-imj-2026-100270-6c5ddd42/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>The document underscores urgent requirements for novel prophylactic and therapeutic development while demonstrating how transnational coordination mechanisms can address complex outbreak environments marked by infrastructure deficits and social friction.</description>
    <category>Ebola</category>
    <category>Outbreak investigation</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Implications for future pandemics from a living systematic review and critical evaluation of observational studies of the effectiveness of COVID-19 vaccination against the Omicron variant</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128993-5ff5f987/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128993-5ff5f987/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>These aggregated results guide international immunization planning and highlight structural improvements needed for future outbreak responses, such as unified research methodologies and integrated health databases.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>2024–2025 BNT162b2 KP.2 COVID-19 full season vaccine effectiveness from vaccine registries linked to administrative claims in two states: A cohort study in non-immunocompromised adults</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-129009-9ffc71a1/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-129009-9ffc71a1/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>Findings support continued COVID-19 vaccine recommendations, demonstrating protection across the 2024-2025 season for adults including those with underlying medical conditions.</description>
    <category>COVID-19</category>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>Effectiveness of Omicron JN.1 vaccination against infection with JN.1-derived SARS-CoV-2 subvariants in a prospective cohort study in the Netherlands</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-129030-f0002f3e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-129030-f0002f3e/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>The findings indicate that JN.1 vaccination provided limited additional protection against SARS-CoV-2 infection during a low-incidence period, with modest effectiveness observed in both age groups. The results contribute to understanding the real-world performance of updated COVID-19 vaccines against emerging subvariants.</description>
    <category>SARS</category>
    <category>COVID-19</category>
    <category>Vaccination</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>Hepatitis B and C Prevention, Screening, and Diagnostic Services at HIV Treatment Sites: International Epidemiology Databases to Evaluate AIDS.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1097-qai-0000000000003896-a601496f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1097-qai-0000000000003896-a601496f/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>Findings point to gaps in HBV and HCV service availability at HIV treatment sites, particularly rural sites, relevant to efforts to address these infections among people receiving HIV care.</description>
    <category>Hepatitis B</category>
    <category>Hepatitis C</category>
    <category>Hepatitis D</category>
    <category>Hepatitis E</category>
    <category>AIDS</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Some Exposure for Influenza Hemagglutinin Interface Antibodies.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1111-imr-70167-2d927d23/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1111-imr-70167-2d927d23/</guid>
    <pubDate>Tue, 01 Sep 2026 00:00:00 GMT</pubDate>
    <description>The article supports continued consideration of vaccine designs that target conserved influenza regions because the abstract describes limited protection from existing vaccines against some seasonal and pandemic viruses. It does not provide evidence of clinical effectiveness for a particular vaccine design.</description>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>The SARS-CoV-2 Integrated Genomic Epidemiology Database (IGED): Linking viral genomes with patient-level metadata to advance statewide genomic surveillance in California</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pdig-0001473-f2024cba/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pdig-0001473-f2024cba/</guid>
    <pubDate>Mon, 31 Aug 2026 00:00:00 GMT</pubDate>
    <description>Centralizing genomic and clinical data streams allows continuous assessment of viral behavior and transmission networks across a large jurisdiction. The established pipeline offers a replicable template for health departments aiming to strengthen routine variant tracking and resource allocation.</description>
    <category>SARS</category>
    <category>COVID-19</category>
    <category>Genomic epidemiology</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>Deconvolving SARS-CoV-2 mRNA Vaccine Impact on Immunotherapy-Related Survival</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1158-2159-8290-cd-26-0403-4efecc0b/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1158-2159-8290-cd-26-0403-4efecc0b/</guid>
    <pubDate>Fri, 28 Aug 2026 00:00:00 GMT</pubDate>
    <description>Within the supplied cancer-care cohorts, the findings do not support interpreting peri-treatment SARS-CoV-2 mRNA vaccination as improving immunotherapy-related survival. The abstract describes the observed early-pandemic association as largely attributable to selection bias involving more favorable-prognosis patients.</description>
    <category>SARS</category>
    <category>COVID-19</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>CLIMATE CHANGE AND CHOLERA TRANSMISSION IN NIGERIA: A SCOPING REVIEW OF DRIVERS, PATTERNS AND CONTROL STRATEGIES</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-66837-ijphrad01-24-09-798861b6/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-66837-ijphrad01-24-09-798861b6/</guid>
    <pubDate>Fri, 28 Aug 2026 00:00:00 GMT</pubDate>
    <description>The review identified surveillance and early-warning systems, water and sanitation improvements, oral cholera vaccination, community engagement, and climate-informed planning as recommended control strategies. It also identified a need for stronger time-series studies, intervention evaluations, and improved integration of climate and health surveillance data.</description>
    <category>Cholera</category>
    <category>Climate and environment</category>
    <category>Transmission dynamics</category>
    <category>Surveillance</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Post-Infectious Cerebellitis: A Systematic Review of Aetiology, Clinical Presentation, Treatment, and Outcomes.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1007-s12311-026-02074-3-199c1b40/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1007-s12311-026-02074-3-199c1b40/</guid>
    <pubDate>Thu, 27 Aug 2026 00:00:00 GMT</pubDate>
    <description>The review maps the clinical spectrum of an immune-mediated post-infectious neurological syndrome across age groups and common viral triggers, which may inform recognition of ataxia syndromes following infection.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Varicella</category>
    <category>Influenza</category>
    <category>Zoster</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Recombinant Influenza Vaccine and Influenza Outbreaks in US Nursing Homes: Results from a Pragmatic Cluster-Randomized Clinical Trial</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-ofid-ofag522-4f2a4986/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-ofid-ofag522-4f2a4986/</guid>
    <pubDate>Thu, 27 Aug 2026 00:00:00 GMT</pubDate>
    <description>The results suggest that deploying this specific immunization strategy may help curb institutional transmission episodes during years with active seasonal pathogen circulation, thereby potentially reducing operational disruptions within elderly care infrastructure.</description>
    <category>Influenza</category>
    <category>COVID-19</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Seroprevalence, associated factors, and molecular detection of hepatitis B virus co-infection among HIV-positive adults in Okene, Nigeria</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-31989-dsn-v5i8-2066-26506a4f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-31989-dsn-v5i8-2066-26506a4f/</guid>
    <pubDate>Thu, 27 Aug 2026 00:00:00 GMT</pubDate>
    <description>The measured infection frequency indicates a persistent dual-viral burden within this regional healthcare setting, reinforcing the value of systematic diagnostic protocols and immunization initiatives.</description>
    <category>Hepatitis D</category>
    <category>Hepatitis B</category>
    <category>AIDS</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Strengthening comprehensive tuberculosis care in Angola: a scoping review of strategies, challenges, and potentialities in a high-burden setting</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-phrs-2026-1609466-20c86831/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-phrs-2026-1609466-20c86831/</guid>
    <pubDate>Thu, 27 Aug 2026 00:00:00 GMT</pubDate>
    <description>The synthesis identifies priority interventions such as guideline updates and workforce training that address documented operational gaps. Enhancing these areas may improve overall disease management capacity within the region.</description>
    <category>Tuberculosis</category>
    <category>Surveillance</category>
    <category>Vaccination</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Rift Valley Fever at Europe’s Risk Frontier: Climate, Vectors, and One Health Preparedness</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-vetsci13090873-69b8cff8/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-vetsci13090873-69b8cff8/</guid>
    <pubDate>Thu, 27 Aug 2026 00:00:00 GMT</pubDate>
    <description>Enhancing early detection capabilities and establishing clear emergency protocols could reduce agricultural economic losses and limit potential cross-species transmission events.</description>
    <category>Rift Valley fever</category>
    <category>Climate and environment</category>
    <category>One Health</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Acute hepatitis B in the vaccination era: Predictors of functional cure and chronicity</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-4254-wjh-124108-0496c536/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-4254-wjh-124108-0496c536/</guid>
    <pubDate>Thu, 27 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings suggest acute HBV infection in the vaccination era carries higher-than-expected chronicity risk, particularly among patients with metabolic disease and socioeconomic disadvantage. This supports the need for early risk stratification and targeted follow-up for vulnerable populations despite vaccine availability.</description>
    <category>Acute hepatitis B</category>
    <category>Hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Hepatitis B in Organ Transplantation-Current Evidence and Clinical Gaps.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1111-tid-70299-d8ebbf59/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1111-tid-70299-d8ebbf59/</guid>
    <pubDate>Wed, 26 Aug 2026 00:00:00 GMT</pubDate>
    <description>By addressing a viral infection affecting hundreds of millions globally, the review highlights how optimized antiviral protocols and broader donor eligibility can enhance transplant system capacity and patient survival.</description>
    <category>Hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Diphtheria mortality at Usmanu Danfodiyo University Teaching Hospital, Sokoto, Nigeria: a review of 98 consecutive cases</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-14298-z-873c0b35/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-14298-z-873c0b35/</guid>
    <pubDate>Wed, 26 Aug 2026 00:00:00 GMT</pubDate>
    <description>The data emphasize the importance of maintaining high childhood vaccination rates and ensuring rapid antitoxin distribution to mitigate severe disease burden in under-resourced regions.</description>
    <category>Diphtheria</category>
    <category>Tetanus</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Acute Varicella Zoster Reactivation After Bipolar Hip Hemiarthroplasty Case Report and Review of the Literature</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-14744-ortst-2026-57654-dbcef60f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-14744-ortst-2026-57654-dbcef60f/</guid>
    <pubDate>Wed, 26 Aug 2026 00:00:00 GMT</pubDate>
    <description>The article describes postoperative herpes zoster as a potential diagnostic consideration in an older patient with acute pain after hip arthroplasty. It also reports that vaccination status was discussed in relation to higher-risk populations.</description>
    <category>Varicella</category>
    <category>Zoster</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Toward Precision Vaccinology for Mpox: Rational Antigen Design, Next-Generation Platforms, and Immune Correlates of Protection</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-tropicalmed11090244-c76236d8/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-tropicalmed11090244-c76236d8/</guid>
    <pubDate>Wed, 26 Aug 2026 00:00:00 GMT</pubDate>
    <description>The article frames precision vaccinology as relevant to mpox preparedness and development of vaccines intended to provide durable, clade-specific protection. The supplied abstract does not provide clinical effectiveness estimates or outcome data supporting a specific public health intervention.</description>
    <category>Monkeypox</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Point prevalence assessments of five respiratory viruses in adults ≥ 50 years of age in Germany by multi-pathogen rapid antigen testing on June 1, 2024, and December 15, 2024.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1007-s15010-026-02917-5-60e9f363/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1007-s15010-026-02917-5-60e9f363/</guid>
    <pubDate>Tue, 25 Aug 2026 00:00:00 GMT</pubDate>
    <description>The authors propose that community-based screening can help identify asymptomatic viral reservoirs and underreported viral circulation, such as adenovirus, linking viral detection to clinical and economic impact.</description>
    <category>SARS</category>
    <category>COVID-19</category>
    <category>Influenza</category>
    <category>Surveillance</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Tularemia: a re-emerging zoonosis.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-medcli-2026-107565-28481b3b/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-medcli-2026-107565-28481b3b/</guid>
    <pubDate>Tue, 25 Aug 2026 00:00:00 GMT</pubDate>
    <description>Tularemia is classified as a CDC Category A bioterrorism agent due to extreme virulence (infection possible with as few as 10 cells) and 30% mortality in untreated cases. The documented re-emergence across multiple Northern Hemisphere regions underscores the need for updated clinical awareness and early diagnostic capacity.</description>
    <category>Tularemia</category>
    <category>Vaccination</category>
    <category>Genomic epidemiology</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>Measles outbreak risk in Afghanistan: provincial immunity gaps and epidemic potential following immunisation system disruption.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-129078-1790fd72/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-129078-1790fd72/</guid>
    <pubDate>Tue, 25 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings suggest that routine one-dose MCV delivery alone is insufficient to reach the measles population-immunity threshold under the model&apos;s central assumptions, and that sustained two-dose routine immunisation, high-reach SIAs, and restored immunisation-system capacity may be required.</description>
    <category>Measles</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Vaccine effectiveness</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered concomitantly with routine pediatric vaccines in healthy infants and toddlers in USA and Puerto Rico: Results from a Phase III, randomized, active-controlled study.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1080-21645515-2026-2716508-f8e301e4/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1080-21645515-2026-2716508-f8e301e4/</guid>
    <pubDate>Tue, 25 Aug 2026 00:00:00 GMT</pubDate>
    <description>Establishing the safety of this vaccine when combined with routine pediatric immunizations aids regulatory approval and clinical administration guidelines. The data contributes to understanding potential interactions within standard infant vaccination protocols.</description>
    <category>Diphtheria</category>
    <category>Tetanus</category>
    <category>Pertussis</category>
    <category>Meningococcal disease</category>
    <category>Varicella</category>
    <category>Hepatitis B</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Randomised controlled trial</category>
  </item>
  <item>
    <title>African Americans&apos; perspective on COVID-19 and influenza vaccines: A qualitative study.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1177-2752535x261481203-1656f630/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1177-2752535x261481203-1656f630/</guid>
    <pubDate>Tue, 25 Aug 2026 00:00:00 GMT</pubDate>
    <description>Identifying these community-specific viewpoints can help shape targeted educational initiatives that address information gaps and strengthen local engagement strategies.</description>
    <category>COVID-19</category>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Commentary</category>
  </item>
  <item>
    <title>From Hepatitis to Encephalitis: Neuroinvasion and Antiviral Development in Rift Valley Fever Virus Infection</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-pathogens15090891-e52a9bda/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-pathogens15090891-e52a9bda/</guid>
    <pubDate>Tue, 25 Aug 2026 00:00:00 GMT</pubDate>
    <description>The work highlights a critical gap in available medical countermeasures for a pathogen with significant agricultural and human health impacts. By outlining a comprehensive evaluation framework, the publication aims to guide the development of treatments that mitigate severe neurological sequelae.</description>
    <category>Rift Valley fever</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>One Health</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Hepatitis B Immunization Among Healthcare Students: A Narrative Review of Occupational Risk, Seroprotection, and Immunization Management</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14090732-18f977c3/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14090732-18f977c3/</guid>
    <pubDate>Tue, 25 Aug 2026 00:00:00 GMT</pubDate>
    <description>The abstract identifies healthcare-student HBV exposure, incomplete vaccination documentation, heterogeneous schedules, and variable institutional protocols as occupational-health and prevention concerns. It describes pre-clinical serological assessment and structured immunization management as operational approaches discussed by the review.</description>
    <category>Hepatitis B</category>
    <category>Viral Hepatitis</category>
    <category>Hepatitis D</category>
    <category>Vaccination</category>
    <category>Surveillance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Interventions for preventing dengue: a mapping review</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1002-14651858-cd016299-pub2-93bce51c/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1002-14651858-cd016299-pub2-93bce51c/</guid>
    <pubDate>Mon, 24 Aug 2026 00:00:00 GMT</pubDate>
    <description>The authors highlight that the main challenge is not a lack of primary studies but the absence of strategic synthesis aligned with decision-making, and call for greater emphasis on epidemiological and implementation outcomes beyond entomological endpoints to support scalable dengue control, particularly in endemic and resource-constrained settings.</description>
    <category>Dengue</category>
    <category>Vaccination</category>
    <category>Climate and environment</category>
    <category>Health policy</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Internists facing emerging arboviral diseases: time to get prepared</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1007-s11739-026-04498-5-77753eae/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1007-s11739-026-04498-5-77753eae/</guid>
    <pubDate>Mon, 24 Aug 2026 00:00:00 GMT</pubDate>
    <description>Environmental shifts and increased human mobility are extending arboviral range into new territories, necessitating heightened clinical awareness. The authors note that aligning bedside evaluation with laboratory standards and community prevention strategies enhances overall disease control efforts.</description>
    <category>Arboviral diseases</category>
    <category>Chikungunya</category>
    <category>Dengue</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Diagnostics</category>
    <category>Climate and environment</category>
    <category>Travel medicine</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Dynamic hinge-motion of PfRIPR revealed by malaria invasion inhibitory antibodies</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41467-026-77069-z-fbf6ba93/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41467-026-77069-z-fbf6ba93/</guid>
    <pubDate>Mon, 24 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings may inform the design of vaccine immunogens based on PfRIPR and improve understanding of structural changes involved in erythrocyte invasion. The abstract does not provide evidence about effects in populations, vaccine effectiveness, or public-health outcomes.</description>
    <category>Malaria</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Viral dissemination and diagnostic insights from experimental infection of sheep with Crimean-Congo hemorrhagic fever virus</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s44298-026-00228-y-f7dccf8b/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s44298-026-00228-y-f7dccf8b/</guid>
    <pubDate>Mon, 24 Aug 2026 00:00:00 GMT</pubDate>
    <description>Because these animals serve as biological amplifiers that facilitate pathogen transfer to arthropod vectors and human populations, clarifying their physiological response may inform broader transmission mitigation efforts and support prophylactic formulation.</description>
    <category>Hemorrhagic Fever</category>
    <category>Crimean-Congo hemorrhagic fever</category>
    <category>Diagnostics</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>BNT162b2 mRNA Vaccination Activates Spike-Reactive Regulatory T Cells in Humans.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-intimm-dxag045-315c0bb4/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-intimm-dxag045-315c0bb4/</guid>
    <pubDate>Mon, 24 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings suggest BNT162b2 mRNA vaccination induces both effector and regulatory T cell responses to spike antigen, indicating that Treg co-induction may be important for balancing antiviral immunity with immunoregulation during COVID-19 vaccination.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Vector competence of temperate and tropical mosquito species for Babanki virus</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0013051-85a54b20/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0013051-85a54b20/</guid>
    <pubDate>Mon, 24 Aug 2026 00:00:00 GMT</pubDate>
    <description>The abstract describes Babanki virus as mosquito-borne and associated with febrile illness, rash, and arthritis in humans and animals, with no specific treatment or vaccine noted. The reported vector competence across multiple mosquito species is relevant to assessing possible emergence risk.</description>
    <category>Dengue</category>
    <category>Western equine encephalitis</category>
    <category>Climate and environment</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Mathematical Analysis and Optimal Control of a Tuberculosis Model with Early Diagnosed Latent Infections</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-28924-2291-8639-24-2026-260-992526eb/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-28924-2291-8639-24-2026-260-992526eb/</guid>
    <pubDate>Mon, 24 Aug 2026 00:00:00 GMT</pubDate>
    <description>The quantitative comparisons assist decision-makers in balancing budgetary limits against the desired magnitude of case reduction during tuberculosis management.</description>
    <category>Tuberculosis</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Inflammation and iron metabolism dysregulation as hallmarks of COVID-19 severity</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-fimmu-2026-1908452-606ef91e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-fimmu-2026-1908452-606ef91e/</guid>
    <pubDate>Mon, 24 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings suggest that inflammatory and iron metabolism biomarkers may help stratify COVID-19 severity and identify mechanisms underlying disease progression, including persistent pathology in severe long COVID-19.</description>
    <category>COVID-19</category>
    <category>Vaccination</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>High mpox mortality in people living with HIV and immune suppression: Lessons from Sierra Leone for integrated outbreak preparedness and response</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-37432-jieph-d-26-00257-853d4094/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-37432-jieph-d-26-00257-853d4094/</guid>
    <pubDate>Mon, 24 Aug 2026 00:00:00 GMT</pubDate>
    <description>The piece argues for integrated HIV/STI and mpox prevention and care, pre-exposure vaccination of at-risk people, continued investment in surveillance and data systems, and pre-approved emergency research protocols as part of outbreak preparedness, with a long-term aim beyond acute response.</description>
    <category>Monkeypox</category>
    <category>HIV infection</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Vaccination</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>Susceptibility of calves fed unpasteurized milk from cows infected with highly pathogenic avian influenza H5N1</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41467-026-76300-1-faba830b/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41467-026-76300-1-faba830b/</guid>
    <pubDate>Fri, 21 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings support preventing unpasteurized milk from H5N1-positive herds or suspect cows from being fed to calves and identify routes of transmission as a research priority for interventions and vaccination strategies.</description>
    <category>H5N1</category>
    <category>Influenza</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>A pseudovirus-based neutralizing antibody assay for measuring neutralizing antibody against rabies virus</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1128-jcm-00877-26-d7dc9058/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1128-jcm-00877-26-d7dc9058/</guid>
    <pubDate>Fri, 21 Aug 2026 00:00:00 GMT</pubDate>
    <description>The assay offers a safer and more accessible alternative to the gold standard RFFIT for post-vaccination antibody screening and monitoring, requiring lower biosafety measures and laboratory resources. This may facilitate broader implementation of serological testing for rabies prevention programs, particularly for identifying vaccine nonresponders at risk of rabies exposure.</description>
    <category>Rabies</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Progress toward poliomyelitis eradication — January 2023–December 2024</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s13690-026-02047-2-9b6ef2f5/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s13690-026-02047-2-9b6ef2f5/</guid>
    <pubDate>Fri, 21 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings highlight the continued risk posed by persistent WPV1 transmission in endemic areas and the geographic spread of cVDPVs, informing the need for improved campaign quality, sustained surveillance, expanded nOPV2 use where cVDPV2 transmission persists, and strategic resource allocation under declining global health funding.</description>
    <category>Poliomyelitis</category>
    <category>Acute flaccid paralysis</category>
    <category>Surveillance</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Climate and environment</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Determinants of post-campaign measles vaccination coverage in Madagascar: A geographically stratified analysis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pgph-0006390-5313a704/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pgph-0006390-5313a704/</guid>
    <pubDate>Fri, 21 Aug 2026 00:00:00 GMT</pubDate>
    <description>The study identifies persistent geographical and socio-demographic inequities in measles vaccination coverage in Madagascar despite overall gains, supporting tailored urban-focused strategies, strengthened communication, improved logistics, and community engagement to advance measles elimination.</description>
    <category>Measles</category>
    <category>Vaccination</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Intranasal delivery of a COBRA-based protein vaccine adjuvanted with c-di-AMP enhances breadth of protective immune responses against seasonal influenza viruses</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-fimmu-2026-1876199-5452e66f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-fimmu-2026-1876199-5452e66f/</guid>
    <pubDate>Fri, 21 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings provide preclinical evidence that a mucosally delivered vaccine strategy targeting multiple influenza antigens may be relevant to research on protection against antigenically drifted seasonal influenza strains. The evidence is limited to mouse immunogenicity and challenge outcomes and does not establish effectiveness in humans.</description>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Organic waste mismanagement, free-roaming dog ecology, and rabies risk in endemic countries: a one health narrative review</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-fitd-2026-1859942-7f317d38/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-fitd-2026-1859942-7f317d38/</guid>
    <pubDate>Fri, 21 Aug 2026 00:00:00 GMT</pubDate>
    <description>Incorporating standardized refuse collection protocols into broader canine rabies eradication plans addresses an often-overlooked ecological contributor to animal-human contact. Multi-agency cooperation that pairs environmental sanitation with veterinary care and public education may enhance progress toward global elimination targets.</description>
    <category>Rabies</category>
    <category>One Health</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
</channel>
</rss>
